New blood glucose monitoring system hits U.S. market
CAESAREA, Israel – The Dario Blood Glucose Monitoring System is now available in the United States, announced its developer, LabStyle Innovations. Through its U.S. headquarters in Massachusetts, the Israeli company is working with insurers to establish reimbursement and arrange agreements with distributors. Direct-to-consumer sales are available at usa.mydario.com/shop are now available and supported through a U.S.-based customer service center and hotline. "The U.S. is the world's largest market for glucose monitoring and the launch of national availability represents a transformative achievement not only for Dario, but more importantly for users," said Erez Raphael, Chairman and CEO of LabStyle Innovations.